Blencowe H, Kancherla V, Moorthie S, Darlison MW, ModellB. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci 2018;1414:31–46.CrossrefWeb of SciencePubMedGoogle Scholar
Borgstedt-Bakke JH, Fenger-Gron M, Rasmussen MM. Correlation of mortality with lesion level in patients with myelomeningocele: a population-based study. J Neurosurg Pediatr 2017;19:227–31.CrossrefPubMedWeb of ScienceGoogle Scholar
Wilson RD, SOGC Genetics Committee, Special Contributor. Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects. J Obstet Gynaecol Can 2014;36:927–39.PubMedCrossrefGoogle Scholar
Carreras E, Maroto A, Illescas T, Melendez M, Arevalo S, Peiro JL, et al. Prenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique. Ultrasound Obstet Gynecol 2016;47:162–7.CrossrefPubMedWeb of ScienceGoogle Scholar
Trigubo D, Negri M, Salvatico RM, Leguizamon G. The role of intrauterine magnetic resonance in the management of myelomenigocele. Childs Nerv Syst 2017;33:1107–11.Web of SciencePubMedCrossrefGoogle Scholar
Appasamy M, Roberts D, Pilling D, Buxton N. Antenatal ultrasound and magnetic resonance imaging in localizing the level of lesion in spina bifida and correlation with postnatal outcome. Ultrasound Obstet Gynecol 2006;27:530–6.CrossrefPubMedGoogle Scholar
About the article
Published Online: 2019-09-04
Published in Print: 2019-09-25
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.